The Tumor program’s research focuses on the development, quality of life, and treatment outcomes for patients experiencing cancer of the musculoskeletal system. The goal is to improve functional ability and patient satisfaction as a result of innovative surgical interventions. Results from our studies will be used to inform doctors, clinical staff, and patients about potential new treatments that improve post-cancer standard of living.
Central Nervous System Metastases in Pediatric Patients With Ewing Sarcoma.
This article evaluates and describes the course of 6 patients with Ewing’s sarcoma who developed metastatic lesions of the central nervous system. View full study
Single cell RNA-sequencing of Ewing sarcoma tumors demonstrates transcriptional heterogeneity and clonal evolution. Single-cell RNA sequencing is used to characterize the transcriptional landscape of primary Ewing’s sarcomas. It was found that these tumor samples have a heterogeneous transcriptional landscape. View full study
Identifying predictors for source culture positivity in children with acute musculoskeletal infections.
This study was looking to see if clinical markers could predict what patients will have a causative pathogen. No predictors were significantly associated with having a causative pathogen found, therefore it is difficult to predict which patients are the highest yield for operative diagnostic procedures. View full study